Synthesis and evaluation of chromone derivatives as inhibitors of monoamine oxidase
| dc.contributor.author | Mpitimpiti, Annah N. | |
| dc.contributor.author | Petzer, Jacobus P. | |
| dc.contributor.author | Petzer, Anél | |
| dc.contributor.author | Jordaan, Johannes H.L. | |
| dc.contributor.author | Lourens, Anna C.U. | |
| dc.contributor.researchID | 12264954 - Petzer, Anél | |
| dc.contributor.researchID | 10727388 - Petzer, Jacobus Petrus | |
| dc.contributor.researchID | 10792341 - Jordaan, Johannes Hendrik Lodewikus | |
| dc.contributor.researchID | 21253005 - Mpitimpiti, Annah Nyasha | |
| dc.contributor.researchID | 10948724 - Lourens, Anna Catharina U. | |
| dc.date.accessioned | 2019-02-28T08:25:22Z | |
| dc.date.available | 2019-02-28T08:25:22Z | |
| dc.date.issued | 2019 | |
| dc.description.abstract | Based on reports that chromone compounds are good potency inhibitors of monoamine oxidase (MAO), the present study evaluates the effect of substitution with flexible side chains on the 3 position on MAO inhibition potency. Fifteen chromone derivatives were synthesised by reacting aromatic and aliphatic amines and alcohols with chromone 3-carboxylic acid in the presence of carbonyldiimidazole (CDI). This yielded chromane-2,4-dione and ester chromone derivatives. Generally, the esters exhibited weak MAO inhibition, while the chromane-2,4-dione derivatives showed promise as selective MAO-B inhibitors with IC50 values in the micromolar range. Compound 14b, 3-[(benzylamino)methylidene]-3,4-dihydro-2H-1-benzopyran-2,4-dione, was the most potent MAO-B inhibitor with an IC50 value of 638 µM. This compound was shown to be a reversible and competitive MAO-B inhibitor with a Ki of 94 µM. In conclusion, the effect of chain elongation and introduction of flexible substituents on position 3 of chromone were explored and the results showed that aminomethylidene substitution is preferable over ester substitution. Good potency MAO-B inhibitors may act as leads for the design and development of therapy for Parkinson’s disease where these agents reduce the central metabolism of dopamine | en_US |
| dc.identifier.citation | Mpitimpiti, A.N. et al. 2019. Synthesis and evaluation of chromone derivatives as inhibitors of monoamine oxidase. Molecular diversity, 23(4):897-913. [https://doi.org/10.1007/s11030-019-09917-8] | en_US |
| dc.identifier.issn | 1381-1991 | |
| dc.identifier.issn | 1573-501X (Online) | |
| dc.identifier.uri | http://hdl.handle.net/10394/31869 | |
| dc.identifier.uri | https://link.springer.com/article/10.1007/s11030-019-09917-8 | |
| dc.identifier.uri | https://doi.org/10.1007/s11030-019-09917-8 | |
| dc.language.iso | en | en_US |
| dc.publisher | Springer | en_US |
| dc.subject | Chromone | en_US |
| dc.subject | Chromandione | en_US |
| dc.subject | Monoamine oxidase | en_US |
| dc.subject | MAO Inhibitor | en_US |
| dc.subject | Competitive | en_US |
| dc.subject | Parkinson’s disease | en_US |
| dc.title | Synthesis and evaluation of chromone derivatives as inhibitors of monoamine oxidase | en_US |
| dc.type | Article | en_US |
Files
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.61 KB
- Format:
- Item-specific license agreed upon to submission
- Description:
